The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review

IF 4.5 Q2 PHARMACOLOGY & PHARMACY
Edgar Selem, Mikolaj Raszek, Joseph Varon, Matthew Halma
{"title":"The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review","authors":"Edgar Selem,&nbsp;Mikolaj Raszek,&nbsp;Joseph Varon,&nbsp;Matthew Halma","doi":"10.1186/s43094-026-00939-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Early assumptions about COVID-19 vaccine components suggested that modified messenger RNA and spike protein would be rapidly cleared from the body, consistent with the known degradation pathways of natural RNA. However, multiple studies have identified these vaccine-derived components in human tissues and bodily fluids for unexpectedly prolonged periods after vaccination. This persistence challenges initial expectations and raises important questions about the mechanisms enabling such long-term presence.</p><h3>Main body</h3><p>This review systematically examines the evidence for enduring COVID-19 vaccine components, including modified messenger RNA, spike protein, and lipid nanoparticles, in the human body long after administration. We evaluate the techniques used to detect these substances, highlighting the sensitivity and specificity of various assays, and summarize the specific tissues and fluids where these components have been found. Special attention is given to methodological considerations that may influence detection and interpretation. Furthermore, this review explores potential biological explanations for the prolonged presence of vaccine-derived material. Possible mechanisms include altered RNA stability due to chemical modifications, slow clearance of lipid nanoparticles, and the formation of stable complexes or reservoirs within tissues. The evidence for each hypothesis is discussed, with an emphasis on distinguishing between true persistence and assay artifacts.</p><h3>Conclusion</h3><p>The reported persistence of COVID-19 vaccine components in the body is a phenomenon that warrants deeper investigation. While methodological factors must be carefully considered, the available data suggest that certain vaccine derivatives may remain detectable for extended periods. Understanding the underlying mechanisms is important for assessing vaccine safety and optimizing future mRNA-based therapeutics.</p><h3>Graphic abstract</h3><p>Figure adapted Halma MTJ, Rose J, Lawrie T (2023) The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review. J 6:220–235. https://doi.org/10.3390/j6020017 under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).</p>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":577,"journal":{"name":"Future Journal of Pharmaceutical Sciences","volume":"12 1","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1186/s43094-026-00939-2.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s43094-026-00939-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Early assumptions about COVID-19 vaccine components suggested that modified messenger RNA and spike protein would be rapidly cleared from the body, consistent with the known degradation pathways of natural RNA. However, multiple studies have identified these vaccine-derived components in human tissues and bodily fluids for unexpectedly prolonged periods after vaccination. This persistence challenges initial expectations and raises important questions about the mechanisms enabling such long-term presence.

Main body

This review systematically examines the evidence for enduring COVID-19 vaccine components, including modified messenger RNA, spike protein, and lipid nanoparticles, in the human body long after administration. We evaluate the techniques used to detect these substances, highlighting the sensitivity and specificity of various assays, and summarize the specific tissues and fluids where these components have been found. Special attention is given to methodological considerations that may influence detection and interpretation. Furthermore, this review explores potential biological explanations for the prolonged presence of vaccine-derived material. Possible mechanisms include altered RNA stability due to chemical modifications, slow clearance of lipid nanoparticles, and the formation of stable complexes or reservoirs within tissues. The evidence for each hypothesis is discussed, with an emphasis on distinguishing between true persistence and assay artifacts.

Conclusion

The reported persistence of COVID-19 vaccine components in the body is a phenomenon that warrants deeper investigation. While methodological factors must be carefully considered, the available data suggest that certain vaccine derivatives may remain detectable for extended periods. Understanding the underlying mechanisms is important for assessing vaccine safety and optimizing future mRNA-based therapeutics.

Graphic abstract

Figure adapted Halma MTJ, Rose J, Lawrie T (2023) The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review. J 6:220–235. https://doi.org/10.3390/j6020017 under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

体液和组织中持续存在的COVID-19疫苗产物:系统综述
关于COVID-19疫苗成分的假设表明,修饰的信使RNA和刺突蛋白将迅速从体内清除,这与已知的天然RNA降解途径一致。然而,多项研究发现,在接种疫苗后,这些疫苗衍生成分在人体组织和体液中存在的时间出乎意料地长。这种持久性挑战了最初的预期,并提出了有关实现这种长期存在的机制的重要问题。本综述系统地研究了COVID-19疫苗成分,包括修饰的信使RNA、刺突蛋白和脂质纳米颗粒,在给药后很长时间内在人体内持续存在的证据。我们评估了用于检测这些物质的技术,强调了各种测定方法的敏感性和特异性,并总结了发现这些成分的特定组织和液体。特别注意可能影响检测和解释的方法方面的考虑。此外,本综述探讨了疫苗衍生物质长期存在的潜在生物学解释。可能的机制包括由于化学修饰而改变的RNA稳定性,脂质纳米颗粒的缓慢清除,以及组织内稳定复合物或储层的形成。讨论了每个假设的证据,重点是区分真正的持久性和分析伪像。结论报告的COVID-19疫苗成分在体内的持久性是一种值得深入研究的现象。虽然必须仔细考虑方法因素,但现有数据表明,某些疫苗衍生物可能在较长时间内仍可检测到。了解潜在机制对于评估疫苗安全性和优化未来基于mrna的治疗方法非常重要。图表摘要图改编自Halma MTJ, Rose J, Lawrie T (2023) mRNA病毒疫苗的新颖性及其潜在危害:范围综述。J 6:220 - 235。https://doi.org/10.3390/j6020017根据知识共享署名(CC BY)许可(https://creativecommons.org/licenses/by/4.0/)的条款和条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
44
审稿时长
23 weeks
期刊介绍: Future Journal of Pharmaceutical Sciences (FJPS) is the official journal of the Future University in Egypt. It is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nano-technology. It also covers development of new systems, methods and techniques in pharmacy education and practice. The scope of the journal also extends to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry and nutraceuticals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书